Article Information
History
- May 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Eva Stadler1,
- Deborah Cromer1,
- Somya Mehra2,
- Adeshina I Adekunle1,3,
- Jennifer A Flegg2,
- Nicholas M Anstey4,
- James A Watson5,6,
- Cindy S Chu5,7,
- Ivo Mueller8,9,
- Leanne J Robinson8,9,10,11,
- Timothy E Schlub1,12,
- Miles P Davenport1 and
- David S Khoury1,*
- 1The Kirby Institute, UNSW Sydney, Sydney, Australia
- 2School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia
- 3Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Australia
- 4Menzies School of Health Research, Darwin University, Darwin, Australia
- 5Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom
- 6Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
- 7Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand
- 8Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
- 9Department of Medical Biology, University of Melbourne, Melbourne, Australia
- 10Burnet Institute, Melbourne, Victoria, Australia
- 11PNG Institute of Medical Research, Madang, Papua New Guinea
- 12Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
- ↵*Correspondence: dkhoury{at}kirby.unsw.edu.au (D. S. Khoury)
Posted May 20, 2022.
Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population
